AP2005003288A0 - Process for the preparation os (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine - Google Patents

Process for the preparation os (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine

Info

Publication number
AP2005003288A0
AP2005003288A0 AP2005003288A AP2005003288A AP2005003288A0 AP 2005003288 A0 AP2005003288 A0 AP 2005003288A0 AP 2005003288 A AP2005003288 A AP 2005003288A AP 2005003288 A AP2005003288 A AP 2005003288A AP 2005003288 A0 AP2005003288 A0 AP 2005003288A0
Authority
AP
ARIPO
Prior art keywords
benzylaminoquinuclidine
benzhydryl
cis
preparation
Prior art date
Application number
AP2005003288A
Other languages
English (en)
Inventor
Thomas C Nugent
Original Assignee
Pfizer Products Inc And Dsm Ph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc And Dsm Ph filed Critical Pfizer Products Inc And Dsm Ph
Publication of AP2005003288A0 publication Critical patent/AP2005003288A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2005003288A 2002-10-16 2003-10-10 Process for the preparation os (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine AP2005003288A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41905102P 2002-10-16 2002-10-16
PCT/US2003/032275 WO2004035575A1 (en) 2002-10-16 2003-10-10 Process for the preparation of (s,s)-cis-2-benzhydryl-3-benzylaminoquinuclidine

Publications (1)

Publication Number Publication Date
AP2005003288A0 true AP2005003288A0 (en) 2005-06-30

Family

ID=32108014

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003288A AP2005003288A0 (en) 2002-10-16 2003-10-10 Process for the preparation os (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine

Country Status (21)

Country Link
US (2) US6861526B2 (https=)
EP (1) EP1551833A4 (https=)
JP (1) JP2006506368A (https=)
KR (1) KR100739901B1 (https=)
CN (1) CN100418964C (https=)
AP (1) AP2005003288A0 (https=)
AR (1) AR041587A1 (https=)
AU (1) AU2003277353B2 (https=)
BR (1) BR0315335A (https=)
CA (1) CA2500635A1 (https=)
EA (1) EA008192B1 (https=)
HR (1) HRP20050328A2 (https=)
IS (1) IS7755A (https=)
MX (1) MXPA05004058A (https=)
PA (1) PA8586601A1 (https=)
PE (1) PE20040777A1 (https=)
PL (1) PL376218A1 (https=)
TN (1) TNSN05111A1 (https=)
UY (1) UY28024A1 (https=)
WO (1) WO2004035575A1 (https=)
ZA (1) ZA200502411B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
JP5021318B2 (ja) * 2004-01-30 2012-09-05 ファイザー・プロダクツ・インク β−シクロデキストリンを液体投薬形態に用いて多用量製剤を達成するための抗菌性防腐剤
KR100812046B1 (ko) * 2004-02-02 2008-03-10 화이자 프로덕츠 인크. 1-(2ｓ,3ｓ)-2-벤즈히드릴-ｎ-(5-삼급-부틸-2-메톡시벤질)퀴누클리딘-3-아민의 제조 방법
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
EP2540725A1 (de) 2006-05-04 2013-01-02 Boehringer Ingelheim International GmbH Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN102256976A (zh) 2008-12-23 2011-11-23 贝林格尔.英格海姆国际有限公司 有机化合物的盐形式
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR20240090632A (ko) 2009-11-27 2024-06-21 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
CN102946875A (zh) 2010-05-05 2013-02-27 贝林格尔.英格海姆国际有限公司 组合疗法
WO2011161161A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US8883800B2 (en) 2011-07-15 2014-11-11 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
JP6218811B2 (ja) 2012-05-14 2017-10-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
JP6224084B2 (ja) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法
CN108341811A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 马罗皮坦杂质的制备方法
CN106977512B (zh) * 2017-05-04 2019-01-01 海门慧聚药业有限公司 制备马罗匹坦游离碱的方法
WO2025172911A1 (en) * 2024-02-16 2025-08-21 Teadus Pharmaceuticals Pvt. Ltd A process for the preparation of (2s,3s)-2-benzhydryl- n-(5-tert-butyl-2-methoxybenzyl) quinuclidin-3-amine and pharmaceutically acceptable salts thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560510A (en) * 1969-03-05 1971-02-02 Aldrich Chem Co Inc 2-benzhydrylquinuclidines
US4680283A (en) 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
US5138060A (en) 1991-01-03 1992-08-11 Pfizer Inc. Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
PL171921B1 (pl) 1991-05-22 1997-06-30 Pfizer Sposób wytwarzania nowych pochodnych podstawionej 3-aminochinuklidyny PL PL PL PL PL
UA27776C2 (uk) * 1991-05-31 2000-10-16 Пфайзер Інк. Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
ATE208376T1 (de) 1992-08-19 2001-11-15 Pfizer Substituierte benzylamin-stickstoff enthaltende nichtaromatische heterocyclen
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists
JP2656699B2 (ja) 1992-10-21 1997-09-24 ファイザー製薬株式会社 置換ベンジルアミノキヌクリジン
JP2656700B2 (ja) 1992-10-28 1997-09-24 ファイザー製薬株式会社 置換キヌクリジン誘導体
DK0668863T3 (da) * 1992-11-12 1997-06-30 Pfizer Quinuclidinderivat som substans P-antagonist
IL109646A0 (en) 1993-05-19 1994-08-26 Pfizer Heteroatom substituted alkyl benzylamino-quinuclidines
PE8798A1 (es) * 1995-07-17 1998-03-02 Pfizer Procedimiento de separacion de los enantiomeros del 1-azabiciclo[2.2.2] octan-3-amina, 2-(difenilmetil) -n- [[2-metoxi-5-(1-metiletil) fenil] metil]
MX9706944A (es) 1996-09-12 1998-08-30 Pfizer Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p.

Also Published As

Publication number Publication date
IS7755A (is) 2005-03-17
US6861526B2 (en) 2005-03-01
HK1078087A1 (en) 2006-03-03
AU2003277353A1 (en) 2004-05-04
CA2500635A1 (en) 2004-04-29
EP1551833A4 (en) 2010-06-02
KR20050083764A (ko) 2005-08-26
EA200500650A1 (ru) 2005-10-27
BR0315335A (pt) 2005-08-16
ZA200502411B (en) 2006-05-31
UY28024A1 (es) 2004-05-31
EP1551833A1 (en) 2005-07-13
AR041587A1 (es) 2005-05-26
JP2006506368A (ja) 2006-02-23
PE20040777A1 (es) 2004-11-20
PA8586601A1 (es) 2005-02-04
PL376218A1 (en) 2005-12-27
MXPA05004058A (es) 2005-06-08
US20040116704A1 (en) 2004-06-17
CN100418964C (zh) 2008-09-17
HRP20050328A2 (en) 2005-06-30
TNSN05111A1 (en) 2007-05-14
WO2004035575A8 (en) 2005-05-12
KR100739901B1 (ko) 2007-07-13
WO2004035575A1 (en) 2004-04-29
EA008192B1 (ru) 2007-04-27
AU2003277353B2 (en) 2007-08-09
US20050085641A1 (en) 2005-04-21
CN1705664A (zh) 2005-12-07

Similar Documents

Publication Publication Date Title
AP2005003288A0 (en) Process for the preparation os (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
MX264256B (es) Proceso para producir hidrolizado de almidon.
IL166710A0 (en) Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile
IL183568A (en) Process for making 7,8-dihydro-5 h-patridine-6-onh
PT2272824T (pt) Processo para a produção de 2,4¿-metilenodifenildiisocianato muito puro
AU2003265589A8 (en) Process for the preparation of 1,1,1,2,2-pentafluoroethane
ZA200402695B (en) Process for the preparation of methanol.
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
PL375695A1 (en) Process for preparing (s)-pantoprazole
EP1561434A4 (en) BITE ATTACHMENT, BIT AND MANUFACTURING PROCESS THEREFOR
IL164248A0 (en) Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
AU2003218704A8 (en) Process for preparing 2-aminoindan derivatives
PL376919A1 (pl) Sposoby wytwarzania 7-karboksy-podstawionych steroidów
EG23417A (en) Process for the preparation 7 a-methylsteroids.
PL377292A1 (pl) Ulepszony sposób wytwarzania 1,3-podstawionych indenów
AU2003275898A1 (en) Process for preparing an adenovirus-containing preparation
ZA200702070B (en) Process for preparing substituted 8-azablcyclo[3.2.1] octan-3-ols
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
MXPA03009210A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.
IL164788A0 (en) Process for the preparation of 3-isochromanone
AU2003284212A8 (en) Process for the preparation of (s,s)-cis-2-phenyl-3-aminopiperidine
HUP0301982D0 (en) Process for the preparation of high purity d-(17alpha)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
AU2003253256A1 (en) Improved process for the preparation of 5-substituted-1-(4--fluorophenyl)-1,3-dihydroisobenzofurans
SG116494A1 (en) Process for producing w-mercaptoalkylpyridine.
EP1386911A3 (de) Verfahren zur Herstellung von Acyloxybenzolsulfonaten